Protagonist Therapeutics Inc buy BTIG Research
Start price
28.10.25
/
50%
€66.00
Target price
28.10.26
€70.34
Performance (%)
28.03%
Price
10.04.26
€84.50
Summary
This prediction is currently active. The prediction currently has a performance of 28.03%. This prediction currently runs until 28.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $82.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
24.07.24
24.07.24
€46.93
24.07.25
24.07.25
-4.16%
25.07.25
25.07.25
